Data Show Substantial Taste Changes in Head and Neck Cancer Following RT

Commentary
Video

Study results appear to affirm anecdotal information from patients with head and neck cancer related to taste changes during and after radiotherapy.

Noah S. Kalman, MD, MBA, spoke with CancerNetwork® about findings from a prospective study presented at the 2024 American Society for Radiation Oncology (ASTRO) Annual Meeting showing significant changes in the ability to perceive taste among patients with head and neck cancer who undergo radiotherapy.

According to Kalman, a radiation oncologist specializing in the treatment of gynecologic, head and neck, thoracic and pediatric cancers, melanoma and non-melanoma skin cancers, and sarcoma at Miami Cancer Institute of Baptist Health Medical Group, data collected via an objective Waterless Empirical Taste Test were consistent with anecdotal information from patients who reported experiences with taste changes following radiotherapy. Overall, taste test scores among this patient population tended to decrease over the course of their treatment.

In total, the relative percentage change in taste at the end of treatment was –16.89%. Specifically, relative changes at the end of treatment based on specific tastes included –9.8% for sweet, –27.03% for sour, –30.36% for salty, –14.88% for bitter, and –65.93% for umami.

Analysis indicated that relative taste changes at the end of therapy strongly correlated with mean tongue doses (Pearson coefficient [r]: –0.6; P <.05). Investigators also noted a moderate association between relative taste changes at this period and oral cavity mean dose (r: –0.54; P <.05).

Transcript:

For our patients undergoing head and neck radiation, we see that their ability to discriminate taste, and so their overall score on these taste tests, go down. This is very much expected. We receive this information anecdotally from our patients, and this is also how we use our subjective grading, and so [the study results are] consistent with that. Over the first 2 to 4 weeks, the patients’ taste decreases substantially, and that continues through the end of treatment. Then as we get past treatment, we have a taste test at the 3-month mark; at that point, these patients are starting to experience recovery of their taste.

Reference

Yarlagadda S, Alzmanzar A, Rubens M, Kalman N. Taste changes in patients receiving head and neck radiation – initial analysis from a prospective study. Presented at: 2024 American Society for Radiation Oncology Annual Meeting; September 29-October 2, 2024; Washington, DC. Abstract 3762.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Retrospective and real-world registry studies may be necessary to guide clinical decision-making for rarer lymphomas with insufficient prospective data.
Extravasation results in exposing healthy tissue to radiation, which can be highly dosed depending on the isotope used for treatment.
Ongoing studies seek to evaluate immunotherapy in earlier lines of therapy for patients with early-stage Hodgkin lymphoma.
Strict inclusion criteria may disproportionately exclude racial minority populations from participating in breast cancer trials.
A paucity of prospective, well-vetted data to guide therapy in patients with rare lymphomas may result in a reliance on expert consensus guidelines.
Testing a patient’s genetics may influence decisions such as using longer courses of radiotherapy, says Rachit Kumar, MD.
Multidisciplinary collaboration may help in minimizing the treatment burden among patients with prostate cancer, according to Curtiland Deville Jr., MD.
Spatial transcriptomics and multiplex immunohistochemistry from samples may elucidate outcomes for patients who undergo surgical care for cancer.
Future work may focus on optimizing symptom management associated with percutaneous transesophageal gastrostomy placement in malignant bowel obstructions.
Related Content